CHICAGO, Dec. 13, 2020 /PRNewswire/ — During the all-virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, leading scientific experts will dive into the groundbreaking advances that are the future of cancer care. One plenary session will focus on the cutting-edge treatment known as T cell therapy, while another will showcase recent discoveries about tumor metabolism that could lead to new, more effective cancer drugs.
Expanding the Reach of T Cell Therapy
T cell therapies train the immune system to target and destroy tumor cells, and have emerged in recent years as a promising alternative to chemotherapy and radiation. Immunotherapy has fewer side effects and has the potential to greatly increase patient survival rates, as T cells can live in the blood for years after a patient’s initial treatment. So far, however, T cell therapy has only received Food and Drug Administration approval for blood cancers such as…
